Koch Disruptive Technologies led the latest round for the ultrasound surgery system developer, which is also backed by GE Healthcare and Elbit Imaging.

Koch Disruptive Technologies, part of industrial and chemicals conglomerate Koch Industries, led a $150m series E round for Israel-based ultrasound surgery technology developer InSightec yesterday.

GE Healthcare, a subsidiary of power and industrial group General Electric, was listed in a statement as an existing investor along with diversified holding company Elbit Imaging, York Capital, Focus Holdings, GEOC and Meditech Advisors, though it was not confirmed that they took part in the round.

InSightec has created a magnetic resonance-based focused ultrasound system that can perform surgery on conditions such as essential tremor, bone metastases and uterine fibroids without surgical incision. The technology was originally licensed from GE and Elbit.

The proceeds from the round, which represents Koch Disruptive Technologies’ first investment, will be used to commercialise the technology as InSightec seeks to expand it into disease areas like brain tumours, Parkinson’s disease and Alzheimer’s disease.

Maurice R. Ferré, chairman and CEO of InSightec, said: “Hospitals around the world are increasingly pursuing incisionless treatment options for their patients using our focused ultrasound therapy.

“This investment round elevates InSightec into a new strategic position within the healthcare industry.”

InSightec has now raised more than $305m altogether, $81m of which came in a two-tranche series D round featuring York Capital that closed in January 2016.

GE Healthcare had joined Elbit and MediTech Advisors to provide $30m for the company in 2007 before investing $27.6m in 2012 as part of a $30.9m series C round. Elbit had also supplied $15m for InSightec in 2009.

– Image courtesy of InSightec Ltd.